Annual CFF
$11.38 M
+$12.97 M+812.27%
December 31, 2023
Summary
- As of February 22, 2025, SEEL annual cash flow from financing activities is $11.38 million, with the most recent change of +$12.97 million (+812.27%) on December 31, 2023.
- During the last 3 years, SEEL annual CFF has fallen by -$14.94 million (-56.77%).
Performance
SEEL Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CFF
$742.00 K
-$1.43 M-65.81%
June 30, 2024
Summary
- As of February 22, 2025, SEEL quarterly cash flow from financing activities is $742.00 thousand, with the most recent change of -$1.43 million (-65.81%) on June 30, 2024.
- Over the past year, SEEL quarterly CFF has dropped by -$1.75 million (-70.20%).
Performance
SEEL Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFF
$7.72 M
+$3.05 M+65.38%
June 30, 2024
Summary
- As of February 22, 2025, SEEL TTM cash flow from financing activities is $7.72 million, with the most recent change of +$3.05 million (+65.38%) on June 30, 2024.
- Over the past year, SEEL TTM CFF has increased by +$561.00 thousand (+7.83%).
Performance
SEEL TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
SEEL Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +812.3% | -70.2% | +7.8% |
| 3 y3 years | -56.8% | +139.3% | +583.7% |
| 5 y5 years | +111.5% | -58.1% | -50.0% |
SEEL Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -89.8% | -114.0% | -96.3% | -411.6% | -93.1% | -120.7% |
| 5 y | 5-year | -89.8% | -114.0% | -98.7% | -411.6% | -93.1% | -120.7% |
| alltime | all time | -89.8% | -116.7% | -98.7% | -1060.8% | -93.1% | -168.8% |
Seelos Therapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2024 | - | $742.00 K(-65.8%) | $7.72 M(+65.4%) |
| Mar 2024 | - | $2.17 M(-6.6%) | $4.67 M(-58.9%) |
| Dec 2023 | $11.38 M(-812.3%) | $2.32 M(-6.7%) | $11.38 M(+58.8%) |
| Sep 2023 | - | $2.49 M(-207.7%) | $7.16 M(+43.1%) |
| Jun 2023 | - | -$2.31 M(-126.1%) | $5.01 M(-30.4%) |
| Mar 2023 | - | $8.87 M(-570.0%) | $7.19 M(-550.5%) |
| Dec 2022 | -$1.60 M(-101.4%) | -$1.89 M(-665.3%) | -$1.60 M(-107.8%) |
| Sep 2022 | - | $334.00 K(-365.1%) | $20.53 M(+0.9%) |
| Jun 2022 | - | -$126.00 K(-251.8%) | $20.34 M(-73.9%) |
| Mar 2022 | - | $83.00 K(-99.6%) | $77.87 M(-30.5%) |
| Dec 2021 | $112.07 M(+325.9%) | $20.24 M(>+9900.0%) | $112.07 M(+9.1%) |
| Sep 2021 | - | $143.00 K(-99.8%) | $102.76 M(-5.7%) |
| Jun 2021 | - | $57.41 M(+67.5%) | $109.00 M(+110.7%) |
| Mar 2021 | - | $34.28 M(+213.4%) | $51.74 M(+96.6%) |
| Dec 2020 | $26.31 M(-10.9%) | $10.94 M(+71.4%) | $26.31 M(+70.4%) |
| Sep 2020 | - | $6.38 M(+4240.1%) | $15.44 M(-12.1%) |
| Jun 2020 | - | $147.00 K(-98.3%) | $17.56 M(-8.5%) |
| Mar 2020 | - | $8.85 M(>+9900.0%) | $19.18 M(-35.0%) |
| Dec 2019 | $29.52 M(+449.1%) | $64.00 K(-99.2%) | $29.52 M(-12.1%) |
| Sep 2019 | - | $8.50 M(+379.2%) | $33.57 M(+52.8%) |
| Jun 2019 | - | $1.77 M(-90.8%) | $21.97 M(-5.7%) |
| Mar 2019 | - | $19.19 M(+366.7%) | $23.29 M(+333.2%) |
| Dec 2018 | $5.38 M(+115.0%) | $4.11 M(-232.3%) | $5.38 M(+284.9%) |
| Sep 2018 | - | -$3.11 M(-200.3%) | $1.40 M(-82.4%) |
| Jun 2018 | - | $3.10 M(+143.0%) | $7.92 M(-27.3%) |
| Mar 2018 | - | $1.27 M(+865.9%) | $10.90 M(+336.0%) |
| Dec 2017 | $2.50 M(-77.3%) | $132.00 K(-96.1%) | $2.50 M(+62.0%) |
| Sep 2017 | - | $3.42 M(-43.7%) | $1.54 M(-17.7%) |
| Jun 2017 | - | $6.08 M(-185.3%) | $1.88 M(-135.3%) |
| Mar 2017 | - | -$7.13 M(+764.1%) | -$5.32 M(-148.3%) |
| Dec 2016 | $11.00 M(-28.8%) | -$825.00 K(-122.0%) | $11.00 M(-2.9%) |
| Sep 2016 | - | $3.75 M(-436.5%) | $11.33 M(-9.9%) |
| Jun 2016 | - | -$1.11 M(-112.1%) | $12.58 M(-7.5%) |
| Mar 2016 | - | $9.19 M(-1953.0%) | $13.59 M(-12.0%) |
| Dec 2015 | $15.45 M(+96.5%) | -$496.00 K(-109.9%) | $15.45 M(-24.4%) |
| Sep 2015 | - | $5.00 M(-5148.5%) | $20.44 M(+11.8%) |
| Jun 2015 | - | -$99.00 K(-100.9%) | $18.27 M(+5.4%) |
| Mar 2015 | - | $11.05 M(+146.1%) | $17.33 M(+120.3%) |
| Dec 2014 | $7.87 M(-52.7%) | $4.49 M(+58.4%) | $7.87 M(+132.4%) |
| Sep 2014 | - | $2.83 M(-372.2%) | $3.38 M(+526.7%) |
| Jun 2014 | - | -$1.04 M(-165.8%) | $540.00 K(-96.9%) |
| Mar 2014 | - | $1.58 M(>+9900.0%) | $17.42 M(+4.8%) |
| Dec 2013 | $16.63 M(-19.9%) | $8000.00(-180.0%) | $16.63 M(-6.8%) |
| Sep 2013 | - | -$10.00 K(-100.1%) | $17.85 M(-0.1%) |
| Jun 2013 | - | $15.84 M(+1902.8%) | $17.87 M(+783.2%) |
| Mar 2013 | - | $791.00 K(-35.7%) | $2.02 M(-90.3%) |
| Dec 2012 | $20.77 M(+170.9%) | $1.23 M(>+9900.0%) | $20.77 M(+4.0%) |
| Sep 2012 | - | $4000.00(-300.0%) | $19.97 M(-11.3%) |
| Jun 2012 | - | -$2000.00(-100.0%) | $22.52 M(-5.1%) |
| Mar 2012 | - | $19.53 M(+4353.7%) | $23.73 M(+209.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2011 | $7.67 M(-52.1%) | $438.60 K(-82.8%) | $7.67 M(-53.9%) |
| Sep 2011 | - | $2.55 M(+111.2%) | $16.64 M(+24.5%) |
| Jun 2011 | - | $1.21 M(-65.2%) | $13.37 M(-15.7%) |
| Mar 2011 | - | $3.47 M(-63.1%) | $15.86 M(-0.8%) |
| Dec 2010 | $15.99 M(+2413.9%) | $9.41 M(-1407.0%) | $15.99 M(+120.1%) |
| Sep 2010 | - | -$720.10 K(-119.5%) | $7.27 M(-9.0%) |
| Jun 2010 | - | $3.69 M(+2.4%) | $7.99 M(+88.3%) |
| Mar 2010 | - | $3.61 M(+425.5%) | $4.24 M(+566.8%) |
| Dec 2009 | $636.10 K(-68.9%) | $686.10 K(>+9900.0%) | $636.10 K(-157.3%) |
| Sep 2009 | - | $0.00(-100.0%) | -$1.11 M(-0.0%) |
| Jun 2009 | - | -$50.00 K(<-9900.0%) | -$1.11 M(-155.4%) |
| Mar 2009 | - | $0.00(-100.0%) | $2.00 M(-1.9%) |
| Dec 2008 | $2.04 M(-207.9%) | -$1.06 M(>+9900.0%) | $2.04 M(-49.0%) |
| Sep 2008 | - | -$500.00(-100.0%) | $4.01 M(-1.0%) |
| Jun 2008 | - | $3.06 M(+7599.0%) | $4.05 M(-303.5%) |
| Mar 2008 | - | $39.80 K(-95.6%) | -$1.99 M(+5.0%) |
| Dec 2007 | -$1.89 M(-112.5%) | $902.70 K(+2128.9%) | -$1.89 M(-139.9%) |
| Sep 2007 | - | $40.50 K(-101.4%) | $4.75 M(+1.8%) |
| Jun 2007 | - | -$2.97 M(-2324.2%) | $4.67 M(-38.5%) |
| Mar 2007 | - | $133.60 K(-98.2%) | $7.59 M(-50.0%) |
| Dec 2006 | $15.18 M(+251.5%) | $7.55 M(<-9900.0%) | $15.18 M(+103.6%) |
| Sep 2006 | - | -$42.40 K(-16.9%) | $7.45 M(-8.1%) |
| Jun 2006 | - | -$51.00 K(-100.7%) | $8.11 M(-33.6%) |
| Mar 2006 | - | $7.72 M(-4459.4%) | $12.22 M(+183.1%) |
| Dec 2005 | $4.32 M(-68.0%) | -$177.20 K(-128.7%) | $4.32 M(-60.6%) |
| Sep 2005 | - | $617.90 K(-84.8%) | $10.96 M(+8.5%) |
| Jun 2005 | - | $4.06 M(-2343.5%) | $10.10 M(-25.3%) |
| Mar 2005 | - | -$180.90 K(-102.8%) | $13.53 M(+0.3%) |
| Dec 2004 | $13.49 M(-46.4%) | $6.47 M(-2806.2%) | $13.49 M(+2.2%) |
| Sep 2004 | - | -$238.90 K(-103.2%) | $13.20 M(-44.4%) |
| Jun 2004 | - | $7.49 M(-3546.3%) | $23.75 M(+2.5%) |
| Mar 2004 | - | -$217.20 K(-103.5%) | $23.17 M(-8.0%) |
| Dec 2003 | $25.19 M(+126.0%) | $6.17 M(-40.1%) | $25.19 M(+26.2%) |
| Sep 2003 | - | $10.31 M(+49.3%) | $19.96 M(+96.0%) |
| Jun 2003 | - | $6.90 M(+283.3%) | $10.18 M(-21.8%) |
| Mar 2003 | - | $1.80 M(+90.7%) | $13.02 M(+16.8%) |
| Dec 2002 | $11.15 M(+1113.6%) | $944.60 K(+77.6%) | $11.15 M(+9.6%) |
| Sep 2002 | - | $532.00 K(-94.5%) | $10.17 M(+3.6%) |
| Jun 2002 | - | $9.74 M(<-9900.0%) | $9.82 M(+7637.2%) |
| Mar 2002 | - | -$69.30 K(+99.7%) | $126.90 K(-86.2%) |
| Dec 2001 | $918.50 K(-97.7%) | -$34.70 K(-118.9%) | $918.40 K(-36.8%) |
| Sep 2001 | - | $183.30 K(+285.1%) | $1.45 M(-94.4%) |
| Jun 2001 | - | $47.60 K(-93.4%) | $26.18 M(-25.4%) |
| Mar 2001 | - | $722.20 K(+44.4%) | $35.10 M(-13.2%) |
| Dec 2000 | $40.42 M(+418.2%) | $500.00 K(-98.0%) | $40.42 M(+1.3%) |
| Sep 2000 | - | $24.91 M(+177.7%) | $39.92 M(+165.9%) |
| Jun 2000 | - | $8.97 M(+48.3%) | $15.01 M(+148.3%) |
| Mar 2000 | - | $6.05 M | $6.05 M |
| Dec 1999 | $7.80 M(+43.0%) | - | - |
| Dec 1998 | $5.46 M(+16.0%) | - | - |
| Dec 1997 | $4.70 M | - | - |
FAQ
- What is Seelos Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Seelos Therapeutics?
- What is Seelos Therapeutics annual CFF year-on-year change?
- What is Seelos Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Seelos Therapeutics?
- What is Seelos Therapeutics quarterly CFF year-on-year change?
- What is Seelos Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Seelos Therapeutics?
- What is Seelos Therapeutics TTM CFF year-on-year change?
What is Seelos Therapeutics annual cash flow from financing activities?
The current annual CFF of SEEL is $11.38 M
What is the all time high annual CFF for Seelos Therapeutics?
Seelos Therapeutics all-time high annual cash flow from financing activities is $112.07 M
What is Seelos Therapeutics annual CFF year-on-year change?
Over the past year, SEEL annual cash flow from financing activities has changed by +$12.97 M (+812.27%)
What is Seelos Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of SEEL is $742.00 K
What is the all time high quarterly CFF for Seelos Therapeutics?
Seelos Therapeutics all-time high quarterly cash flow from financing activities is $57.41 M
What is Seelos Therapeutics quarterly CFF year-on-year change?
Over the past year, SEEL quarterly cash flow from financing activities has changed by -$1.75 M (-70.20%)
What is Seelos Therapeutics TTM cash flow from financing activities?
The current TTM CFF of SEEL is $7.72 M
What is the all time high TTM CFF for Seelos Therapeutics?
Seelos Therapeutics all-time high TTM cash flow from financing activities is $112.07 M
What is Seelos Therapeutics TTM CFF year-on-year change?
Over the past year, SEEL TTM cash flow from financing activities has changed by +$561.00 K (+7.83%)